Specialty code 183500000X · Stockton, CA
NPI
1487891354
Since 2009
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
7373 West Ln
Stockton, CA, 95210
Phone (209) 476-5113
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$431K
2,600 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jessica Marie V Bugay prescribed most often to Medicare patients was Atorvastatin Calcium, with 398 prescriptions and refills. In total Jessica Marie V Bugay wrote 2,600 Medicare prescriptions that cost $431K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 398 | 1,327 | 140 | $4,949 |
| Glipizide Generic | 261 | 868 | 97 | $3,555 |
| Ozempic Semaglutide | 235 | 242 | 43 | $174K |
| Metformin Hcl Generic | 209 | 695 | 73 | $2,636 |
| Humulin N Insulin Nph Human Isophane | 144 | 444 | 53 | $33K |
| Metformin Hcl Er Metformin Hcl | 143 | 477 | 53 | $1,450 |
| Humulin R Insulin Regular, Human | 113 | 335 | 42 | $25K |
| Jardiance Empagliflozin | 101 | 337 | 39 | $63K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 76 | 241 | 24 | $25K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 74 | 236 | 29 | $2,061 |
| Amlodipine Besylate Generic | 67 | 223 | 23 | $802 |
| Lisinopril Generic | 62 | 207 | 23 | $790 |
| Glipizide Er Glipizide | 55 | 183 | 26 | $1,789 |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 54 | 180 | 26 | $1,984 |
| Simvastatin Generic | 47 | 157 | 18 | $548 |
Brand drugs: 855 claims; generic drugs: 1,532 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jessica Marie V Bugay were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.